Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N2CG
|
|||
| Former ID |
DNCL002774
|
|||
| Drug Name |
Carlecortemcel-L
|
|||
| Synonyms |
Stemex (TN)
Click to Show/Hide
|
|||
| Indication | Hematologic tumour [ICD-11: 2B33.Y] | Phase 2/3 | [1] | |
| Lung infection [ICD-11: CA4Z] | Phase 2/3 | [1] | ||
| Company |
Gamida Cell; Teva North America
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00469729) Efficacy and Safety Study of StemEx, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.